Parker-Hannifin Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Parker-Hannifin Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	12,029	14,302	14,320	13,696	14,348	15,862	19,065	19,930	19,850	21,499
Cost of revenue	9,119	10,738	10,689	10,292	9,605	10,550	12,636	12,802	12,535	13,397
Gross profit	2,840	3,565	3,631	3,403	4,743	5,311	6,429	7,128	7,315	8,102
Research and development	337	328	295	237	205	191	258	253	240	267
Selling, general and administrative	1,413	1,640	1,544	1,657	2,383	2,504	3,354	3,315	3,255	3,468
Operating income	1,790	2,038	2,236	1,967	2,460	2,975	3,404	4,069	4,347	5,068
Interest expense	162	214	190	308	250	255	574	506	409	401
Other non-operating income	-49.6	-122	-96.6	-152	37.1	-1,106	-150	32	169	-104
Pre-tax income	1,329	1,702	1,949	1,507	2,247	1,614	2,680	3,595	4,107	4,563
Income tax	345	641	424	305	500	298	596	750	575	914
Net income to minority interests	0.43	0.51	0.57	0.36	0.76	0.58	1	1	1	1
Net income	983	1,061	1,525	1,202	1,746	1,316	2,083	2,844	3,531	3,648
EBITDA	1,993	2,276	2,462	2,220	2,730	3,232	3,721	4,418	4,701	5,421
EPS, basic	7.37	7.98	11.73	9.36	13.54	10.24	16.23	22.13	27.52	28.89
EPS, diluted	7.25	7.83	11.57	9.26	13.35	10.09	16.04	21.84	27.12	28.48
Shares, basic (weighted)	133	133	130	128	129	129	128	129	128	126
Shares, diluted (weighted)	136	135	132	130	131	130	130	130	130	128
Dividend per share	2.58	2.74	3.16	3.52	3.67	4.42	5.47	6.07	6.69	7.40

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	885	822	3,220	686	733	536	475	422	467	501
Short-term investments	39.3	33	151	70.8	39.1	27.9	8.39
Receivables	1,931	2,146	2,131					2,866	2,910	3,170
Inventory	1,549	1,621	1,678	1,964	2,091	2,215	2,908	2,787	2,839	3,166
Other current assets	120	135	182	215	244	6,383	315	140	153	200
Total current assets	4,780	5,085	7,673	5,035	5,617	12,047	6,834	6,799	6,950	7,695
Property, plant and equipment	1,937	1,856	1,768	2,293	2,266	2,123	2,865	2,876	2,937	3,020
Lease right-of-use assets				139	132	133	233	226	192	201
Goodwill	5,587	5,504	5,454	7,870	8,060	7,740	10,629	10,507	10,694	11,109
Intangible assets	2,307	2,016	1,783	3,799	3,520	3,136	8,451	7,816	7,374	7,280
Other non-current assets								1,207	1,269	1,535
Total assets	15,490	15,320	17,732	19,888	20,341	25,944	29,964	29,298	29,494	30,877
Accounts payable	1,300	1,430	1,413	1,112	1,668	1,732	2,051	1,992	2,126	2,439
Accrued liabilities	436	428	426	424	507	470	651	581	587	658
Deferred revenue			64.7	51.3	51.2	60.5	245	184	211	192
Short-term debt	474	100	0.23	86	2.82	302	1,974	1,255	7	706
Total current liabilities	3,396	3,197	3,152	3,148	3,097	5,859	7,735	7,313	5,819	6,096
Long-term debt	4,862	4,319	6,521	7,652	6,582	9,756	8,796	7,157	7,494	6,766
Lease liabilities				96.4	93.9	100	187	180	154	164
Other non-current liabilities	337	526	438	539	639	522	893	726	733	748
Total liabilities	10,223	9,455	11,609	13,646	11,928	17,084	19,626	17,217	15,803	15,464
Total debt	5,336	4,419	6,521	7,738	6,585	10,058	10,771	8,412	7,501	7,472
Paid-in capital	544	497	462	417	330	327	306	264	194	818
Retained earnings	10,930	11,626	12,778	13,644	14,915	15,662	17,042	19,105	21,775	24,487
Treasury stock	-4,379	-4,590	-5,309	-5,365	-5,371	-5,688	-5,818	-5,950	-7,495	-9,189
Other comprehensive income	-1,924	-1,763	-2,059	-2,559	-1,567	-1,543	-1,293	-1,438	-883	-803
Shareholders' equity	5,262	5,860	5,962	6,227	8,398	8,848	10,327	12,072	13,682	15,404
Minority interests	5.7	5.63	6.18	14.5	15.4	11.9	11.4	9	9	9
Total equity	5,267	5,971	6,086	6,242	8,414	8,860	10,338	12,081	13,691	15,413
Total liabilities and equity	15,490	15,320	17,577	19,888	20,341	25,944	29,964	29,298	29,494	30,877

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	984	1,061	1,525	1,202	1,747	1,316	2,084	2,845	3,532	3,649
Depreciation and amortization	203	238	226	253	270	257	317	349	354	353
Stock-based compensation	80.3	119	104	111	121	137	143	155	159	179
Deferred income tax	37	-41.4	36.4	12.3	-51.5	-351	92	32	-304	-4
Change in receivables	-95.3	-302	2.45	579	-299	-179	-17	-85	6	-114
Change in inventory	-73.7	-92.2	-67.9	207	-85.6	-212	53	101	-94	-272
Cash from operations	1,301	1,597	1,730	2,071	2,575	2,442	2,980	3,384	3,776	4,364
Capital expenditures	-204	-248	-195	-233	-210	-230	-381	-400	-435	-459
Acquisitions	-4,069	0	-2.04	-5,076	0	0	-7,146	0	0	-1,014
Purchases of investments	-466	-80.6	-182	-195	-34.8	-27.9	-37.8	-17.2
Sales and maturities of investments	1,279	83.9	74.9	275	79.4	31.8	56.8	24.3
Cash from investing	-3,363	23.7	-219	-5,024	-0.01	-419	-8,177	-298	224	-1,390
Debt issued	2,614	1.19	2,337	1,721	1.21	3,598	2,023	24	751	23
Debt repaid	-381	-945	-213	-740	-1,212	-18.7	-2,341	-2,385	-1,741	-24
Stock issued	2.2	3.68	2.48	2.62	4.68	2.83	3	4	4
Share buybacks	-338	-381	-860	-216	-219	-460	-297	-332	-1,766	-1,262
Dividends paid	-345	-365	-412	-454	-475	-570	-704	-782	-861	-936
Cash from financing	1,783	-1,682	902	449	-2,623	3,916	-971	-3,115	-3,977	-2,934
Exchange rate effect	-56.7	-1.15	-16.3	-30.5	96	-23.8	-5	-24	22	-6
Net change in cash	-337	-62.7	2,398	-2,534	47.6	5,915	-6,173	-53	45	34
Free cash flow	1,097	1,349	1,535	1,838	2,365	2,212	2,599	2,984	3,341	3,905
Interest paid	132	201	169	308	237	240	465	491	384	385
Income taxes paid	268	409	455	308	486	549	411	852	927	1,064

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $978.33 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	37.7%	Gross profit / revenue.
Operating margin	23.6%	Operating income / revenue.
EBITDA margin	25.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	21.2%	Pre-tax income / revenue.
Net margin	17.0%	Net income / revenue.
FCF margin	18.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	20.3%	Cash from operations / revenue.
Effective tax rate	20.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	25.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	12.1%	Net income / average total assets.
Return on invested capital (ROIC)	18.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	1.2%	Research and development expense / revenue.
SG&A / revenue	16.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.1%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	10.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	8.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	16.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	14.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	15.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	15.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	13.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	14.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	3.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	20.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	15.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	5.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	21.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	16.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	15.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	13.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	11.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	16.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	14.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	10.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	10.6%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	10.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	15.1%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	14.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	12.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	4.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	1.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.26x	Current assets / current liabilities.
Quick ratio	0.60x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.08x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.49x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	24.2%	Total debt / total assets.
Liabilities / assets	50.1%	Total liabilities / total assets.
Net debt	$6.97B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.29x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	12.6x	Operating income / interest expense.
Working capital	$1.60B	Current assets - current liabilities.
Goodwill and intangibles / assets	59.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$2.99B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.71x	Revenue / average total assets.
Fixed asset turnover	7.22x	Revenue / average property, plant and equipment.
Inventory turnover	4.46x	Cost of revenue / average inventory.
Days inventory	82 days	365 x average inventory / cost of revenue.
Receivables turnover	7.07x	Revenue / average receivables.
Days sales outstanding	52 days	365 x average receivables / revenue.
Days payables	62 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	71 days	Days inventory + days sales outstanding - days payables.
FCF conversion	107.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	10.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$28.48	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$28.89	Net income per basic share, as reported (split-adjusted).
Revenue per share	$167.83	Revenue / diluted weighted shares.
FCF per share	$30.48	Free cash flow / diluted weighted shares.
Operating cash flow per share	$34.07	Cash from operations / diluted weighted shares.
Book value per share	$120.25	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$23.30	Tangible book value / shares outstanding.
Cash per share	$3.91	(Cash + short-term investments) / shares outstanding.
Dividend per share	$7.40	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	25.7%	Dividends paid / net income, when net income is positive.
Dividends / FCF	24.0%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	32.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$123.35B	Share price x shares outstanding.
Enterprise value	$130.33B	Market cap + total debt - cash - short-term investments.
P/E	33.8x	Market cap / net income. Only when net income is positive.
P/S	5.74x	Market cap / revenue.
P/B	8.01x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	31.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	28.3x	Market cap / cash from operations, when positive.
EV/Sales	6.06x	Enterprise value / revenue.
EV/EBIT	25.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	24.0x	Enterprise value / EBITDA, when both are positive.
EV/FCF	33.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.2%	Free cash flow / market cap.
Earnings yield	3.0%	Net income / market cap (the inverse of P/E).
Dividend yield	0.8%	Dividends paid over the period / market cap.
Shareholder yield	1.8%	(Dividends paid + share buybacks) / market cap.
PEG	1.60x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Parker-Hannifin Corp's revenue in fiscal 2026?

Parker-Hannifin Corp reported revenue of $21.50B for fiscal 2026, 8.3% higher than the year before.

Was Parker-Hannifin Corp profitable in fiscal 2026?

Yes. Net income was $3.65B, a net margin of 17%.

How much free cash flow did Parker-Hannifin Corp generate in fiscal 2026?

Cash from operations of $4.36B minus capital expenditures of $459.0M left free cash flow of $3.91B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Parker-Hannifin Corp